Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about The Oncology Institute, Inc.
The Oncology Institute, Inc. News
The Oncology Institute, Inc. Quantitative Score
About The Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
The Oncology Institute, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
The Oncology Institute, Inc. Financials
Table Compare
Compare TOI metrics with: | |||
|---|---|---|---|
Earnings & Growth | TOI | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | TOI | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | TOI | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | TOI | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
The Oncology Institute, Inc. Income
The Oncology Institute, Inc. Balance Sheet
The Oncology Institute, Inc. Cash Flow
The Oncology Institute, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Strong Buy |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
The Oncology Institute, Inc. Executives
| Name | Role |
|---|---|
| Dr. Daniel Virnich FACHE, M.B.A., M.D. | Chief Executive Officer & Executive Director |
| Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. | Chief Medical Officer |
| Mr. Jeremy N. Castle M.B.A. | Chief Operations Officer |
| Mr. Austin Lee | Vice President of Accounting & Controller |
| Mr. Mark Hueppelsheuser Esq. | General Counsel |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Dr. Daniel Virnich FACHE, M.B.A., M.D. | Chief Executive Officer & Executive Director | 1979 | 704.25K | |
| Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. | Chief Medical Officer | 1972 | 573.76K | |
| Mr. Jeremy N. Castle M.B.A. | Chief Operations Officer | Male | 1984 | 475.95K |
| Mr. Austin Lee | Vice President of Accounting & Controller | Male | -- | |
| Mr. Mark Hueppelsheuser Esq. | General Counsel | Male | -- |
The Oncology Institute, Inc. Insider Trades
| Date | 4 Sep |
| Name | M33 Growth I L.P. |
| Role | Director, 10 percent owner |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 6018168 |
| Date | 4 Sep |
| Name | M33 Growth I L.P. |
| Role | Director, 10 percent owner |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 681832 |
| Date | 19 Aug |
| Name | Hively Brad |
| Role | Director |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 20221 |
| Date | 12 Aug |
| Name | BARASCH RICHARD A |
| Role | Director |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 24 Jul |
| Name | BARASCH RICHARD A |
| Role | Director |
| Transaction | Disposed |
| Type | J-Other |
| Shares | 287756 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 4 Sep | M33 Growth I L.P. | Director, 10 percent owner | Disposed | S-Sale | 6018168 |
| 4 Sep | M33 Growth I L.P. | Director, 10 percent owner | Disposed | S-Sale | 681832 |
| 19 Aug | Hively Brad | Director | Disposed | S-Sale | 20221 |
| 12 Aug | BARASCH RICHARD A | Director | Disposed | 0 | |
| 24 Jul | BARASCH RICHARD A | Director | Disposed | J-Other | 287756 |